HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nitza Lahat Selected Research
Nitza Lahat Research Topics
Disease
10
Hypoxia (Hypoxemia)
10/2011 - 04/2002
4
Ischemia
10/2011 - 08/2003
3
Neoplasms (Cancer)
02/2016 - 11/2002
3
Inflammation (Inflammations)
01/2012 - 08/2003
2
Hyperoxia
01/2012 - 03/2009
2
Infections
07/2008 - 01/2003
2
Celiac Disease (Celiac Sprue)
10/2002 - 08/2002
1
Pneumonia (Pneumonitis)
01/2012
1
Bronchopulmonary Sequestration (Pulmonary Sequestration)
01/2012
1
Leukopenia
01/2012
1
Thrombocytopenia (Thrombopenia)
01/2012
1
Sepsis (Septicemia)
01/2012
1
Glaucoma
07/2011
1
Blister (Bulla)
07/2011
1
Renal Cell Carcinoma (Grawitz Tumor)
10/2010
1
Heart Failure
03/2010
1
Systolic Heart Failure
03/2010
1
Reperfusion Injury
03/2009
1
Ganglion Cysts (Ganglion)
05/2007
1
Autoimmune Diseases (Autoimmune Disease)
11/2003
1
Chronic Progressive Multiple Sclerosis
11/2003
1
Viral Meningitis
01/2003
1
Meningitis
01/2003
1
Multiple Sclerosis
10/2002
Drug/Important Bio-Agent (IBA)
7
Matrix Metalloproteinases (MMPs)
IBA
02/2016 - 10/2002
6
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2012 - 08/2003
6
Messenger RNA (mRNA)
IBA
10/2011 - 04/2002
6
Proteins (Proteins, Gene)
FDA Link
10/2011 - 04/2002
5
Tissue Inhibitor of Metalloproteinase-2
IBA
07/2011 - 04/2002
4
Cytokines
IBA
03/2010 - 08/2003
3
Oxygen (Dioxygen)
IBA
01/2012 - 09/2003
3
matrigel
IBA
03/2011 - 11/2005
3
Matrix Metalloproteinase 14 (MT1-MMP)
IBA
11/2005 - 04/2002
2
Interleukin-10 (Interleukin 10)
IBA
10/2011 - 03/2010
2
Tissue Inhibitor of Metalloproteinase-1
IBA
07/2011 - 05/2007
2
Transcription Factors (Transcription Factor)
IBA
03/2011 - 01/2011
2
Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
IBA
10/2010 - 09/2003
2
Lipopolysaccharides
IBA
07/2008 - 08/2003
2
pro-matrix metalloproteinase 9
IBA
05/2007 - 04/2006
2
Enzymes
IBA
09/2003 - 04/2002
2
Antibodies
IBA
10/2002 - 08/2002
2
Matrix Metalloproteinase 2 (Gelatinase A)
IBA
10/2002 - 04/2002
2
Protein Glutamine gamma Glutamyltransferase 2
IBA
10/2002 - 08/2002
1
Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))
IBA
02/2016
1
Epitopes
IBA
02/2016
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
02/2016
1
L-Selectin
IBA
01/2012
1
HLA-DR Antigens (HLA-DR)
IBA
10/2011
1
Antigens
IBA
10/2011
1
Interleukin-2 (IL2)
IBA
10/2011
1
progelatinase
IBA
07/2011
1
Mitomycin (Mitomycin-C)
FDA Link
Generic
07/2011
1
Coloring Agents (Dyes)
IBA
10/2010
1
MicroRNAs (MicroRNA)
IBA
10/2010
1
Nitric Oxide (Nitrogen Monoxide)
FDA Link
10/2010
1
Free Radicals
IBA
03/2009
1
Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
IBA
07/2008
1
bafilomycin A1
IBA
07/2008
1
Nitric Oxide Synthase (NO Synthase)
IBA
05/2007
1
salicylhydroxamic acid (SHAM)
IBA
05/2007
1
Retinaldehyde (Retinal)
IBA
05/2007
1
Matrix Metalloproteinase Inhibitors
IBA
05/2007
1
Metalloproteases (Metalloproteinases)
IBA
05/2007
1
Minocycline (Cyclops)
FDA Link
Generic
05/2007
1
Matrix Metalloproteinase 9 (Gelatinase B)
IBA
04/2006
1
Integrins
IBA
11/2005
1
Peptide Hydrolases (Proteases)
FDA Link
11/2005
1
Integrin beta3 (GPIIIa)
IBA
11/2005
1
Interferon-beta
IBA
11/2003
1
Actinin
IBA
09/2003
1
Nitrites
IBA
09/2003
1
Interleukin-8 (Interleukin 8)
IBA
01/2003
1
Biomarkers (Surrogate Marker)
IBA
01/2003
1
Interleukins
IBA
01/2003
1
Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
IBA
01/2003
1
Intravenous Immunoglobulins (IVIG)
FDA Link
11/2002
1
gamma-Globulins (gamma-Globulin)
IBA
11/2002
1
Interferons
IBA
10/2002
1
Interferon-gamma (Interferon, gamma)
IBA
10/2002
Therapy/Procedure
2
Therapeutics
02/2016 - 11/2003
1
Ligation
01/2012
1
Punctures
01/2012
1
Filtering Surgery
07/2011
1
Trabeculectomy (Trabeculoplasty)
07/2011